MCT inhibitor + MPC inhibitor

This refers to a combination therapy or compound that simultaneously inhibits monocarboxylate transporters (MCTs) and the mitochondrial pyruvate carrier (MPC). MCT inhibitors block the transport of monocarboxylates such as lactate, pyruvate, and ketone bodies across cell membranes, thereby affecting cellular metabolism and energy production[2]. MPC inhibitors prevent the import of pyruvate into mitochondria, disrupting mitochondrial metabolism and reducing oxidative phosphorylation[1]. Both classes are under investigation for their potential in treating metabolic diseases and cancer by targeting altered cellular energy pathways.